Latest SLE Stories
ATLANTA, June 16 /PRNewswire-FirstCall/ -- UCB (Euronext: UCB) and Immunomedics, Inc. (Nasdaq: IMMU) announced new lupus drug candidate, epratuzumab, provided a significant reduction in disease activity in patients with moderate to severe active systemic lupus erythematosus (SLE).
EXTON, Pa., June 15 /PRNewswire/ -- BioTrends is pleased to announce the upcoming publication of a new syndicated report, TreatmentTrendsÂ®: Systemic Lupus Erythematosus (SLE).
HAYWARD, Calif., June 10 /PRNewswire-FirstCall/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing therapeutics to treat serious diseases associated with inflammation and autoimmune disorders, today announced it has updated its Lupus Scientific Advisory Board.
Paves way for safety testing of potential new use for asthma drug.
Study finds SLE patients at risk for developing atherosclerosis.
In the new Swedish-Finnish study, published in Nature Genetics, the researchers identified five loci that predispose to an SLE-related disease in Nova Scotia duck tolling retrievers.
MUHC researchers link smoking to skin problems in people with SLE.
Patients with the autoimmune disease systemic lupus erythematosus (SLE) have an increased risk of infection, due to both disturbances in their immune responses and treatment with immunosuppressive drugs.
Psychopharmaceutical use has risen over recent years. This is fact, but what is not clear is the reason why. Researchers from four Madrid-based health centers have shown that family conflict is not a significant factor.
ROCKVILLE, Maryland and LONDON, July 20 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc.